Astrotech CorpASTC
Price$7.51Intrinsic value$10.4940% above price

Qualitative Analysis

Business overview

Business Overview

Astrotech Corporation (NASDAQ: ASTC) is a science and technology development company that focuses on commercializing innovative technologies sourced from internal research, universities, and laboratories. Historically centered on analytical instrumentation and astrochemistry, the company operates through several key subsidiaries. 1st Detect develops and manufactures mass spectrometry-based chemical analyzers, notably the TRACER 1000 trace detection system used in airport security and military applications. AgLAB develops mass spectrometers for the agriculture and cannabis markets, while BreathTech focuses on breath-analysis screening tools. In mid-2026, Astrotech announced a major strategic pivot, approving a board-backed initiative to expand into space-based hardware infrastructure, lunar resource development, and Moon-based quantum computing manufacturing.

Research as of 20 Jun 2026

Strategic Initiatives

Growth programs, investments, and their expected impact

AI-assisted
Lunar Resource and Infrastructure InitiativeInnovation

A strategic pivot focused on lunar resource development, autonomous lunar industrial infrastructure, and future Moon-based advanced computing and semiconductor manufacturing opportunities. The initiative targets four categories: Silicon/Si-28 for quantum computing, Helium-3 for quantum cooling, Platinum Group Metals (PGMs) for terrestrial use, and water ice for propellant/life support.

Expected impact: Positions Astrotech at the forefront of the emerging commercial lunar economy, leveraging its operational spaceflight heritage to build off-world manufacturing and computational infrastructure.

Sign in / Sign up to read more
InvestmentTo be funded in part by the potential sale of the 1st Detect subsidiary.
TimelineLong-term framework aligned with NASA's Artemis and CLPS programs.
Commercialization of TRACER 1000 and EN-SCANGrowth

Transitioning from the research and development stage to active commercial sales and field trials for the 1st Detect TRACER 1000 and EN-SCAN Handheld GC product lines, including expanding international deployments and government channel access.

Expected impact: Aims to drive near-term revenue growth and reduce operating losses by capitalizing on recent European (ECAC) and U.S. (TSA) regulatory certifications.

Sign in / Sign up to read more
InvestmentSelective investment in sales pipeline and field trials, offset by a 28% reduction in R&D expenses in Q3 FY2026.
TimelineOngoing

Mergers, Acquisitions & Partnerships

Recent deals and strategic collaborations

AI-assisted

Strategic Partnerships

U.S. Department of Homeland Security (DHS)Research and Development Contract

Awarded contract 70RSAT24CB0000015 to research, develop, and mature the TRACER 1000 for DHS next-generation explosives trace detection.

Terms: Contract with a total potential value of $1,290,650 over 30 months

Sign in / Sign up to read more
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.